Status:
ACTIVE_NOT_RECRUITING
The Cardio-Sarcopenia Study
Lead Sponsor:
National Heart Centre Singapore
Conditions:
Cardiac Ageing
Physical Activity
Eligibility:
All Genders
21-99 years
Brief Summary
The use of surrogate markers such as body mass index (BMI) as a target outcome of physical activity may not be appropriate in older adults who are at risk of muscle sarcopenia. In the presence of sarc...
Detailed Description
This study builds upon our group's work where we characterized cardiovascular and skeletal muscle structure and function of community-based older adults. In this proposal, we will identify n=100 parti...
Eligibility Criteria
Inclusion
- \>=21 years of age
Exclusion
- Unable to provide written informed consent to participate in the study.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2051
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05203406
Start Date
May 1 2022
End Date
December 31 2051
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart Centre Singapore
Singapore, Singapore, Singapore, 169609